|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Medical Imaging and Radiation Sciences, College of Allied Health, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
Correspondence: For correspondence or reprints contact: Vesper Grantham, University of Oklahoma Health Sciences Center, P.O. Box 26901/CHB 451, Oklahoma City, OK 73190. E-mail: vesper-grantham{at}ouhsc.edu
ABSTRACT
The use of 51Cr-labeled red blood cells to determine erythrocyte survival in circulation is not a routine procedure. Data are acquired by frequent counting of small-volume blood samples to determine the rate of red cell survival over time. Results are entirely quantitative and can involve semilogarithmic graphing techniques. An accurate study can positively identify hemolytic anemia, a disorder characterized by premature destruction of erythrocytes. Additionally, anatomic sites of premature hemolysis will demonstrate a higher radioactive count than the background organ. This procedure review presents a dual survival and sequestration study positive for hemolytic anemia and hypersplenism in an 83-y-old man with systemic lupus erythematosus. 51Cr red cell survival and splenic sequestration studies may be considered when clinical history and laboratory studies cannot establish a definitive diagnosis.
Key Words: hemolytic anemia; red cell survival; splenic sequestration
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| THE JOURNAL OF NUCLEAR MEDICINE | JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY |